From Wikipedia, the free encyclopedia
Jump to: navigation, search
KannaLife Sciences Inc.
Industry Pharmaceutical
Founded 2010
Founders Dean Petkanas, Thoma Kikis
Headquarters Doylestown, Pennsylvania And Huntington, New York
Total assets Exclusive License of patent US 6630507 
Website http://kannalife.com
KannaLife was granted the Exclusive License by NIH-OTT for the commercialization of patent US 6630507  “Cannabinoids as Antioxidants and Neuroprotectants."

KannaLife Sciences Inc. is a bio-pharmaceutical and phyto-medical company based in Huntington, NY and Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis.[1] KannaLife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants. It is a portfolio company of Medical Marijuana, Inc..[2]

In 2011, the company was granted an Exclusive License[3] by National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of patent US 6630507 , “Cannabinoids as Antioxidants and Neuroprotectants."[4]

KannaLife is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County[5] in Doylestown, PA, for a target drug candidate to treat Hepatic encephalopathy and CTE,[6] an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain.